The study of hypoxia imaging using FAZA

The study of hypoxia imaging using FAZA(1-(5-[18 F]Fluoro-5-deoxy-alpha-D-arabinofuranosyl)-2-nitroimidazole) - The study of hypoxia imaging using FAZA

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000039594

Enrollment

Registered

2020-04-01

Start date

2020-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic disease, malignant tumor

Interventions

FAZA PET/CT

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Assured for (F-18) FDG PET/CT, greater than or equal to 20 year of age with written informed consent

Exclusion criteria

Exclusion criteria: 1.The case who is difficult to participate in the study due to psychological disorders and other diseases. 2.The case who is judged as inappropriate by the physician

Design outcomes

Primary

Measure	Time frame
the uptake of [F-18] FAZA in lesions	—

Countries

Japan

Contacts

Public ContactJunichi Tsuchiya

Medical Hospital Tokyo Medical and Dental University Department of Diagnostic Radiology

tcymrad@tmd.ac.jp03-5803-5311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026